Interleukln 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice

Journal of Experimental Medicine

Volumn 178, Issue 1, 1993, Pages 87-99

  Rapoport, Micha J ^a   Jaramillo, Andrés ^a   Zipris, Danny ^a,e   Lazarus, Alan H ^a   Serreze, David V ^b   Leiter, Edward H ^b   Cyopick, Paul ^c   Danska, Jane S ^d   Delovitch, Terry L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b JACKSON LABORATORY   (United States)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CELL PROLIFERATION; CELL STRAIN 3T3; CROSS LINKING; DIABETES MELLITUS; GENETIC RECOMBINATION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOSTIMULATION; MOUSE; PRIORITY JOURNAL; THYMOCYTE;

ANIMAL; ANTIGENS, CD4; ANTIGENS, CD8; DIABETES MELLITUS, INSULIN-DEPENDENT; FEMALE; INTERLEUKIN-2; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL; RECEPTORS, INTERLEUKIN-2; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES;

EID: 0027272228     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.178.1.87     Document Type: Article

References (53)

1. Blackman, M., J. Kappler, and P. Marrack. 1990. Role of the T cell receptor in positive and negative selection of developing T cells. Science (Wash. DC). 248:1335.
2. Sinha, A., C. Lopez, and H.O. McDevitt. 1990. Autoimmune diseases: the failure of self tolerance. Science (Wish. DC). 248:1380.
3. Schwartz, R.H. 1990. A cell culture model for T lymphocyte clonal anergy. Science (Wash. DC). 248:134.
4. Ramsdell, F., and B.J. Fowlkes. 1990. Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance. Science (Wash. DC). 248:1342.
5. Castano, L., and G.S. Eisenbarth. 1990. Type I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu. Rev. Immunol. 8:647.
6. Zipris, D., A.R. Crow, and T.L. Delovitch. 1991. Altered thymic and peripheral T-lymphocyte repertoire precedes the onset of diabetes in NOD mice. Diabetes. 40:429.
7. Zipris, D., A.H. Lazarus, A.R. Crow, M. Hadzija, and T.L. Delovitch. 1991. Defective thymic T cell activation by Con A and anti-CD3 in autoimmune NOD mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis. J. Immunol. 146:3763.
8. Rapoport, M.J., D. Zipris, A.H. Lazarus, A. Jaramillo, and T.L. Delovitch. 1991. Altered T cell development and function in prediabetic NOD mice: mechanism and relevance to disease. In HLA 1991. Vol. 2. T. Sasazuki, editor. Oxford University Press. Oxford. 112-121.
9. DeSilva, D.R., K.B. Urdahl, and M.K. Jenkins. 1991. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J. Immunol. 147:3261.
10. Mueller, D.L., L. Chiodetti, P.A. Bacon, and R.H. Schwartz. 1991. Clonal anergy blocks the response to IL4, as well as the production of IL2, in dual-producing T helper cell clones. J. Immunol. 147:4118.
11. Swain, S.L., L.M. Bradley, M. Croft, S. Tokonogy, G. Atkins, A.D. Weinberg, D.D. Duncan, S.M. Hedrick, R.W. Dutton, and G. Huston. 1991. Helper T cell subsets: phenotype, function, and role of lymphokines in regulating their development. Immunol. Rev. 123:115.
12. Ceredig, R., J. Lowenthal, M. Nabholz, and H.R. MacDonald. 1985. Expression of interleukin-2 receptors as a differentiation marker of intrathymic stem cells. Nature (Land.). 314:98.
13. Kubo, R.T., and N. Roehm. 1986. Preparation and characterization of a “pan-reactive” rabbit anti-mouse T cell receptor anti-serum. Mol. Immunol. 23:869.
14. Leo, O., M. Foo, D.H. Sachs, L.E. Samelson, and J.A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA. 84: 1374.
15. Ohara, J., and W.E. Paul. 1985. Production of a monoclonal antibody to and molecular characterization of B cell stimulatory factor 1. Nature (Lond.). 315:33.
16. Mosmann, T.R., H. Cherwinski, M.W. Bond, M.A. Giedlin, and R.L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.
17. Karasuyama, H., and F. Melchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:97.
18. Ben-Sasson, S.Z., G. Le Gross, D.H. Conrad, F.D. Finkelman, and W.E. Paul. 1990. IL-4 production by T cells from naive donors. IL2 is required for IL4 production. J. Immunol. 145:1127.
19. Li, J.H., J. Ohara, C. Watson, W. Tsang, and W.E. Paul. 1989. Derivation of a T cell line that is highly responsive to IL4 and IL2 (CT.4R) and of an IL2 hyporesponsive mutant of that line (CT.4S). J. Immunol. 142:800.
20. Gillis, S., and K.A. Smith. 1977. Long term culture of tumor-specific cytotoxic T cells. Nature (Lond.). 268:154.
21. Robb, R. J. W.C. Greene, and C.M. Rusk. 1984. Low and high affinity cellular receptors for interleukin 2. Implications for the level of TAC antigen. J. Exp. Med. 160:1126.
22. Serreze, D.V., and E.H. Leiter. 1988. Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies. J. Immunol. 140:3801.
23. Smith, K.A. 1988. Interleukin 2: inception, impact, and implications. Science (Wash. DC). 240:1169.
24. + T cells by Staphylococcal enterotoxin B. J. Exp Med. 172:1091.
25. Hatamori, N., K. Yokono, M. Nagata, K. Shii, and S. Baba. 1990. Impaired mitogen-induced expression of high-affinity interleukin 2 receptors on spleen cells from NOD/Shi/Kbe mice. Diabetes. 39:1070.
26. Roberts, J.L., S.O. Sharrow, and A. Singer. 1990. Clonal deletion and clonal anergy in the thymus induced by cellular elements with different radiation sensitivities. J. Exp Med. 171:935.
27. Williams, M.E., A.H. Lichtman, and A.K. Abbas. 1990. Anti-CD3 antibody induces unresponsiveness to IL2 in Thl clones but not Th2 clones. J. Immunol. 144:1208.
28. Barcena, A., M.L. Toribio, J.C. Gutierrez-Ramos, G. Kroemer, and A.C. Martinez. 1990. Interplay between IL2 and IL4 in human thymocyte differentiation: antagonism or agonism. Int. Immunol. 3:419.
29. Martinez, C.M., R.C. Gibbons, M.R. Garovoy, and F.R. Aronson. 1990. IL4 inhibits IL2 receptor expression and IL2 dependent proliferation of human T cells. J. Immunol. 144:2211.
30. Spits, H., H. Yessel, Y. Takebe, N. Arai, T. Yokota, F. Lee, K. Arai, J. Banchereau, and J.E. De Vries. 1987. Recombinant interleukin 4 promotes the growth of human T cells. J. Immunol. 139:1142.
31. Mossman, T.R., and R.L. Coffman. 1989. Thl and Th2 cells: different patterns of lymphocyte secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
32. las activation. J. Exp Med. 177:1221.
33. Leiter, E.H. 1989. The genetics of diabetes susceptibility in mice. FASEB (Fed. Am. Soc. Exp Biol.) J. 3:2231.
34. Serreze, D.V., K. Hamaguchi, and E.H. Leiter. 1990. Im-munostimulation circumvents diabetes in NOD/Lt mice. J. Autoimmun. 2:759.
35. Klausner, R.D., and L.E. Samelson. 1991. T cell antigen receptor activation pathways: The tyrosine kinase connection. Cell. 64:875.
36. Tanaka, T., S.Z. Ben-Sasson, and W.E. Paul. 1991. IL4 increases IL2 production by T cells in response to accessory cell-independent stimuli. J. Immunol. 146:3831.
37. Mitchell, L.C., L.S. Davis, and P.E. Lipsky. 1989. Promotion of human T lymphocyte proliferation by IL-4. J. Immunol. 142:1548.
38. Lorre, K., J.V. Damme, and J.L. Ceuppens. 1990. A bidirectional regulatory network involving IL-2 and IL4 in the alternative CD2 pathway of T cell activation. Eur. J. Immunol. 20:1569.
39. LeGros, G., S.Z. Ben-Sasson, R. Seder, F.D. Finkelman, and W.E. Paul. 1990. Generation of interleukin 4 (IL4)-producing cells in vivo and in vitro: IL2 and IL-4 are required for in vitro generation of IL4 producing cells. J. Exp Med. 172:921.
40. + T cells and their roles in the induction and prevention of autoimmunity. Immunol. Rev. 123:37.
41. + T cell subset that inhibits this autoimmune potential. J. Exp Med. 177:627.
42. + lymphocyte subpopulation in prediabetic subjects. Diabetes. 40:590.
43. Faustman, D., X. Li, H.Y. Lin, Y. Fu, G. Eisenbarth, J. Avruch, and J. Guo. 1991. Linkage of faulty major histocompatibility complex class I to autoimmune diabetes. Science (Wash. DC). 254:1756.
44. Shehadeh, N., F. La Rosa, and K.J. Lafferty. 1993. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. In press.
45. Debray-Sachs, M., C. Carnaud, C. Boitard, H. Cohen, I. Gresser, P. Bedossa, and J.F. Bach. 1991. Prevention of diabetes in NOD mice treated with antibody to murine IFN-gamma. J. Autoimmun. 4:237.
46. Burstein, H.J., and A.K. Abbas. 1993. In vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen. J. Exp Med. 177:457.
47. Bendelac, A., and R.H. Schwartz. 1991. THO cells in the thymus: the question of T-helper lineages. Immunol. Rev. 123: 169.
48. Lewis, D.B., C.C. Lu, K.A. Forbush, J. Carpenter, T.A. Sato, A. Grossman, D.H. Liggit, and R.M. Perlmutter. 1990. Interleukin 4 expressed in situ selectively alters thymocyte development. J. Exp Med. 173:89.
49. Satoh, J., H. Seino, T. Abo, S. Tanaka, S. Shintani, S. Ohta, K. Tamura, T. Sawai, T. Nobunaga, T. Oteki, K. Kumagai, and T. Toyota. 1989. Recombinant human tumor necrosis factor a suppresses autoimmune diabetes in NOD mice. J. Clin. Invest. 84:1345.
50. Jacob, C.O., S. Aiso, A. Michie, H.O. McDevitt, and H. Acha-Orbea. 1990. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-a and interleukin 1. Proc. Natl. Acad. Sci. USA. 87:968.
51. Satoh, J., K. Oya, S. Shintani, T. Okano, T. Toyota, R. Suzuki, and K. Kumagui. 1986. Biological response modifier prevents NOD mouse from IDDM. Meeting Abstract: New Horizons in Animal Models for Autoimmune Disease. Tokyo, Japan, pg. 66a.
52. Dauphinee, M.J., S.B. Kipper, D. Wofsy, and N. Talal. 1981. Interleukin-2 deficiency is a common feature of autoimmune mice. J. Immunol. 127:2483.
53. Zier, K.S., M.M. Leo, R.S. Spielman, and L. Baker. 1984. Decreased synthesis of interleukin-2 (IL-2) in insulin-dependent diabetes mellitus. Diabetes. 33:552.